- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03531398
Postprandial Responses to Typical UK Meal Nutrient Profiles (Pre-PREDICT)
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Background: Dietary fat consumption is one of the major modifiable risk factors implicated in the causation of cardiovascular disease (CVD). Postprandial lipaemia (PPL); the increase in circulating blood triacylglycerol (TAG) concentrations after a fat containing meal, is an independent risk factor for cardiovascular disease. However, little is known about how different doses of fats as found in typical UK meals will influence the level of PPL.
The majority of research into PPL, including work by our own group and others has largely focused on the postprandial effect following high fat meals, with the primary goal of assessing mechanisms underlying fat metabolism. However, these findings are not relevant from a public health perspective; in reality the average fat content of a meal is much lower than this (~20- 30 g fat, (NDNS, 2013/4)); therefore it is important to assess the impact of doses of fat in this range on PPL to be relevant to public health. The few dose response studies that have been performed assessing fat load and PPL have used liquid test meals that are not relevant to every day meals.
PPL is usually measured by taking a series of blood samples from a cannula, however this is an invasive procedure. There has been an increase in the development of less invasive biochemical assessment, e.g. urine or saliva analysis or dried blood spot (DBS) analysis. DBS analysis is particularly advantageous as samples can be easily collected by the individual under assessment with minimal equipment and transferred easily for analysis via the post, providing simple home-testing. Frequently, postprandial research studies will draw blood from the cannula for multiple related outcomes and therefore, performing multiple assays from one DBS sample would be advantageous in minimizing participant discomfort.
Aim: The primary aim of the current study is to investigate the postprandial response following typical UK meal nutrient profiles containing 20-30g fat. Secondary aims will be to test the feasibility for measuring PPL, insulin, c-peptide and performing metabolomic analysis from DBS versus serum blood analysis. Further, it will assess the best practice for collection (venous versus finger prick) and storage (ambient versus freezer) of the DBS samples.
Hypothesis: Typical UK meal nutrient profiles will elicit detectable PPL. Further, DBS will be an effective method for measuring postprandial outcomes.
Expected value: The study will provide novel information on the effect of fat doses from typical UK meals on PPL. It will also provide feasibility for using DBS for measuring postprandial responses.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
UK
-
London, UK, Det Forenede Kongerige, SE1 9NH
- King's College London
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Males and females aged 18-65 years.
- Free of diagnosed diseases listed in exclusion criteria.
- Able to understand the information sheet and willing to comply with study protocol.
- Able to give informed consent.
Exclusion Criteria:
Refuse or are unable to give informed consent to participate in the study
- BMI >32 kg/m2
- BP >170/100 mm Hg
- Have had long term inflammatory disease or cancer in the last three years.
- Have had long term gastrointestinal disorders including inflammatory bowel disease (IBD) or Coeliac disease (gluten allergy).
- Are taking the following daily medications: immunosuppressants, antibiotics in the last three months
- Are long-term users of PPIs, unless they are able to stop two weeks before the start of the study.
- Have type I diabetes mellitus or type II diabetes mellitus.
- Are currently suffering from acute clinically diagnosed depression.
- Have had a heart attack (myocardial infarction) or stroke in the last 6 months.
- Are pregnant
- Are vegan, suffering from an eating disorder or unwilling to take foods that are part of the study.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: High fat meal
Muffin containing 30g fat
|
Metabolic test meal challenge
|
Eksperimentel: Medium fat meal
Muffin containing 20g fat
|
Metabolic test meal challenge
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Postprandial lipaemia
Tidsramme: 0-4 hours postprandially
|
Change in serum triglycerides
|
0-4 hours postprandially
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Postprandial glycaemia
Tidsramme: 0-4 hours postprandially
|
Change in plasma glucose
|
0-4 hours postprandially
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Postprandial plasma insulin
Tidsramme: 0-4 hours postprandially
|
Change in plasma insulin
|
0-4 hours postprandially
|
Postprandial plasma c-peptide
Tidsramme: 0-4 hours postprandially
|
Change in plasma C-peptide
|
0-4 hours postprandially
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- HR-17/18-5652
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Ernæring
-
Duke UniversityAfsluttetBehandling og forebyggelse af anæmi efter administration af Gudness Nutrition BarIndien
Kliniske forsøg med Metabolic test meal challenge
-
Nanjing Medical UniversityIkke rekrutterer endnuErnæring | MetabolismeforstyrrelseKina
-
University Hospitals Cleveland Medical CenterSomaLogic, Inc.AfsluttetType 2 diabetesForenede Stater
-
Children's Hospital of PhiladelphiaAktiv, ikke rekrutterendeDehydrering hos børn | VæsketerapiForenede Stater
-
University of ExeterRoyal Devon and Exeter NHS Foundation TrustRekrutteringHypoglykæmi | Type 1 diabetesDet Forenede Kongerige
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RekrutteringMetaboliske sygdomme | Type 2 diabetes | Genetisk dispositionForenede Stater
-
University of FloridaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) og andre samarbejdspartnereAfsluttet
-
AHS Cancer Control AlbertaCross Cancer InstituteAfsluttet
-
Medical University of GrazNovo Nordisk A/SAfsluttetType 1 diabetes mellitusØstrig
-
University of EdinburghNHS LothianAfsluttet
-
Vanderbilt UniversityAfsluttetForhøjet blodtryk | Type 2 diabetes mellitusForenede Stater